Regional Treatment Flow and Prognosis ofTraumatic Thoracic Aortic Injuries:A Multi-center Retrospective Analysis in Zhejiang Province During 11 Years

NCT04934878 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 234

Last updated 2021-07-15

No results posted yet for this study

Summary

Using keywords (main) artery dissection aneurysm (main) artery haematoma (main) To diagnose X-ray imaging reports and medical record home page is a search, check the unit 11 hospitals in Zhejiang Province during the year aortic injury clinical data of 11 years, through the electronic questionnaire to fill in the form of information, information of diagnosis and treatment of the basic information for the patient injury mechanism and so on carries on the statistical analysis. Basic information includes gender, age, history of hypertension. Injury information includes injury mechanism information and trauma information. Injury mechanism refers to injuries caused by car accidents, high falls and other causes. Injury information includes diagnosis, injury severity score, Glasgow coma index, and Stanford classification of aortic injury. The information of diagnosis and treatment includes the method of treatment, the reason for referral, the time of definitive treatment and the prognosis. The method of treatment is divided into the first treatment group and the referral group. The first treatment group refers to the patients admitted by the hospital for the first time, and the referral group refers to the patients transferred from other hospitals. The reasons for referral include: the suggestion of the hospital after comprehensive consideration, the lack of diagnosis and treatment qualification of the hospital, the subjective will of the patient's family members. Deterministic treatment time refers to the time from injury to imaging examination and the time from injury to surgery and other data to be statistically analyzed.

Conditions

  • Severe Trauma
  • Blunt Thoracic Aortic Injury
  • Interventional Therapy
  • Treatment Protocal

Interventions

BIOLOGICAL

Referral information

first visit to our hospital/transfer from another hospital

Sponsors & Collaborators

  • Hwa Mei Hospital, University of Chinese Academy of Sciences

    collaborator UNKNOWN
  • Zhoushan Hospital Zhejiang Province

    collaborator UNKNOWN
  • Taizhou Hospital Zhejiang Province

    collaborator UNKNOWN
  • Quzhou People's Hospital Zhejiang Province

    collaborator UNKNOWN
  • First Affiliated Hospital of Wenzhou Medical University

    collaborator OTHER
  • Second Affiliated Hospital of Wenzhou Medical University

    collaborator OTHER
  • Shaoxing People's Hospital

    collaborator OTHER
  • Ningbo No. 1 Hospital

    collaborator OTHER
  • The Central Hospital of Lishui City

    collaborator OTHER
  • Ningbo Medical Center Li Huili Hospital

    collaborator UNKNOWN
  • Lishui People's Medical

    collaborator UNKNOWN
  • Jinhua Central Hospital

    collaborator OTHER
  • 903 Hospital of Chinese People's Liberation Army

    collaborator OTHER
  • Affiliated Hospital of Jiaxing University

    collaborator OTHER
  • The Second Affiliated Hospital of Jiaxing University

    collaborator OTHER
  • First People's Hospital of Hangzhou

    collaborator OTHER
  • Zhejiang Quhua Hospital

    collaborator OTHER
  • Yinzhou Second Hospital

    collaborator UNKNOWN
  • Tiantai County People's Hospital

    collaborator UNKNOWN
  • Taizhou Hospital

    collaborator OTHER
  • The First People's Hospital of Huzhou

    collaborator OTHER
  • Suichang County People's Hospital

    collaborator UNKNOWN
  • Quzhou Second People's Hospital

    collaborator UNKNOWN
  • Ningbo Fenghua District People's Hospital

    collaborator UNKNOWN
  • Jiangshan People's Hospital

    collaborator UNKNOWN
  • Second Affiliated Hospital, School of Medicine, Zhejiang University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-19
Primary Completion
2021-02-01
Completion
2021-03-01
FDA Drug
Yes

Countries

  • China

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04934878 on ClinicalTrials.gov